Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
GV
AddedFeb 11, 2024
UpdatedJul 16, 2026
GV

GV

Operating

Alphabet Inc.'s venture capital arm, GV, invests in innovative companies across diverse sectors since 2009.

Location
Mountain View, CA, US
Founded
2009
Firm
Compare
Portfolio
Employees
News
Website

Investments

Nebex
Nebex
Seed

Total Raised

$30M

Rounds

1

Seed$30MJune 2026
Oblenio Bio
Oblenio Bio
Series B

Total Raised

$62M

Rounds

1

Series B$62MJune 2026
MokN
MokN
Series A

Total Raised

$15M

Rounds

1

Series A$15MMay 2026
Isomorphic Labs
Isomorphic Labs

Total Raised

$2.8B

Rounds

3

Series B$2.1BMay 2026
Series A$600MMarch 2025
Sierra
Sierra

Total Raised

$1.6B

Rounds

4

Series E$950MMay 2026
OpenEvidence
OpenEvidence

Total Raised

$630M

Rounds

5

Series C$200MOctober 2025
Series B$100MJuly 2025
PostHog
PostHog

Total Raised

$182.2M

Rounds

7

Series E$75MSeptember 2025
Series D$70MJune 2025
Harvey
Harvey
Series F

Total Raised

$906M

Rounds

6

Series E$300MJune 2025
Tennr
Tennr
Series C

Total Raised

$161M

Rounds

5

Series C$101MJune 2025
Series B$37MOctober 2024
Hebbia
Hebbia
Series B

Total Raised

$161.1M

Rounds

3

Series B$130MJuly 2024
Accent Therapeutics
Accent Therapeutics

Total Raised

$178M

Rounds

3

Series C$75MJanuary 2024
Comanche Biopharma
Comanche Biopharma

Total Raised

$111.1M

Rounds

2

Series B$75MJanuary 2024
Granata Bio
Granata Bio

Total Raised

$14.1M

Rounds

2

Series A$14MJanuary 2024
FlutterFlow
FlutterFlow

Total Raised

$28M

Rounds

3

Series A$25.5MJanuary 2024
Moonwalk Biosciences
Moonwalk Biosciences

Total Raised

$57M

Rounds

2

Series A$57MJanuary 2024
Lightmatter
Lightmatter

Total Raised

$422M

Rounds

5

Series C$155MDecember 2023
Tome Biosciences
Tome Biosciences

Total Raised

$213M

Rounds

1

Series A$213MDecember 2023
Seismic Therapeutic
Seismic Therapeutic

Total Raised

$222M

Rounds

2

Series B$121MDecember 2023
Blockchain.com
Blockchain.com

Total Raised

$600M

Rounds

10

Series E$110MNovember 2023
Layer Health
Layer Health

Total Raised

$4M

Rounds

1

Seed$4MNovember 2023
Gate Bioscience
Gate Bioscience

Total Raised

$60M

Rounds

1

Series A$60MNovember 2023